Inhibition of tumor necrosis factor α-stimulated aromatase activity by microtubule-stabilizing agents, paclitaxel and 2-methoxyestradiol

Biochemical and Biophysical Research Communications

Volumn 261, Issue 1, 1999, Pages 214-217

  Purohit, A ^a   Singh, A ^a   Ghilchik, M W ^a   Reed, M J ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; AROMATASE; INTERLEUKIN 6; PACLITAXEL; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROXYLATION; MICROTUBULE; PRIORITY JOURNAL; STROMA CELL;

EID: 0033595162     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1999.1010     Document Type: Article

References (22)

1. Reed M. J., Owen A. M., Lai L. C., Coldham N. G., Ghilchik M. W., Shaikh N. A., James V. H. T. Int. J. Cancer. 44:1989;233-237.
2. Reed M. J., Coldham N. G., Patel S., Ghilchik M. W., James V. H. T. J. Endocrinol. 132:1992;R5-R8.
3. Macdiarmid F., Wang D., Duncan L. J., Purohit A., Ghilchik M. W., Reed M. J. Molec. Cell. Endocrinol. 106:1994;17-21.
4. Zhao Y., Agarwal V., Mendelson C. R., Simpson E. R. Endocrinology. 137:1996;5739-5742.
5. Kelly P. M., Davison R. S., Bliss E., McGee J. O. Br. J. Cancer. 57:1988;174-177.
6. Purohit A., Ghilchik M. W., Duncan L. J., Wang D. Y., Singh A., Walker M. M., Reed M. J. J. Clin. Endocrinol. Metab. 80:1995;3052-3058.
7. Reed M. J., Purohit A. Endocrine Rev. 18:1997;701-715.
8. Stewart T., Tsai S.-C. J., Grayson H., Henderson R., Opelz G. Lancet. 346:1995;796-798.
9. Singh A., Purohit A., Duncan L. J., Mokbel K., Ghilchik M. W., Reed M. J. J. Steroid Biochem. Molec. Biol. 61:1997;185-192.
10. Tartaglia L. A., Goeddel D. V. Immunol. Today. 13:1992;151-153.
11. Ding A. H., Porteu F., Sanchez E., Nathan C. F. Science. 248:1990;370-373.
12. Attalla H., Makela T. P., Adlercreutz H., Andersson L. C. Biochem. Biophys. Res. Comm. 228:1996;467-473.
13. Attalla H., Westberg J. A., Andersson L. C., Adlercreutz H., Makela T. P. Biochem. Biophys. Res. Comm. 247:1998;616-619.
14. Yue T.-L., Wang X., Londen C. S., Gupta S., Pillarisetti K., Gu J.-L., Hart T. K., Lykso P. G., Feuerstein G. Z. Molec. Pharmacol. 51:1997;951-962.
15. Ding A. H., Porteu F., Sanchez E., Nathan C. F. J. Exp. Med. 171:1990;715-727.
16. Schrey M. P., Patel K. V. Br. J. Cancer. 72:1995;1412-1419.
17. Zhu B. T., Conney A. H. Cancer Res. 58:1998;2269-2277.
18. Fotsis T., Zhang Y., Pepper M. S., Adlercreutz H., Montesano R., Nawroth P. P., Schweigerer L. Nature. 368:1994;273-239.
19. Klauber N., Parangi S., Flynn E., Hamel E., D'Amato R. J. Cancer Res. 57:1997;81-86.
20. Bradlow H. L., Sepkovic D. W., Telang N. T., Osborne M. P. Ann. N.Y. Acad. Sci. 728:1995;180-200.
21. Bradlow H. L., Telang N. T., Sepkovic D. W., Osborne M. P. J. Endocrinol. 150:1996;S259-S265.
22. Simpson E., Rubin G., Clyne C., Robertson K., O'Donnell L., Davis S., Jones M. Endocr. Rel.-Cancer. 6:1999;131-137.